Dr. Noemi Salang Ramsay, MD

Anesthesiology Little Rock, AR Female
NPI: 1508822735
Total Payments
$3,758
2024 Payments
$517.42
Companies
36
Transactions
203
Medicare Patients
8,116
Medicare Billing
$1.6M

Payment Breakdown by Category

Food & Beverage$3,758 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,758 203 100.0%

Top Paying Companies

Company Total Records Latest Year
Collegium Pharmaceutical, Inc. $911.20 52 $0 (2024)
Daiichi Sankyo Inc. $690.79 52 $0 (2019)
PFIZER INC. $217.06 11 $0 (2021)
Flexion Therapeutics, Inc. $198.71 5 $0 (2019)
Scilex Pharmaceuticals Inc. $142.84 8 $0 (2019)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $138.69 7 $0 (2024)
Averitas Pharma Inc. $129.76 2 $0 (2024)
AstraZeneca Pharmaceuticals LP $127.96 8 $0 (2019)
US WorldMeds, LLC $127.76 1 $0 (2019)
Horizon Pharma plc $110.86 2 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $517.42 20 Collegium Pharmaceutical, Inc. ($316.36)
2023 $240.31 13 Collegium Pharmaceutical, Inc. ($171.52)
2022 $294.75 18 Collegium Pharmaceutical, Inc. ($221.81)
2021 $390.13 27 Collegium Pharmaceutical, Inc. ($130.33)
2020 $272.33 14 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($59.63)
2019 $783.08 34 Flexion Therapeutics, Inc. ($167.58)
2018 $702.58 51 Daiichi Sankyo Inc. ($368.19)
2017 $557.51 26 Daiichi Sankyo Inc. ($203.52)

All Payment Transactions

203 individual payment records from CMS Open Payments — Page 1 of 9

Date Company Product Nature Form Amount Type
12/11/2024 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $22.44 General
Category: Opioid Analgesic
11/21/2024 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $24.19 General
Category: Opioid Analgesic
11/13/2024 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $23.34 General
Category: Opioid Analgesic
10/23/2024 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $20.50 General
Category: Opioid Analgesic
10/16/2024 VERTEX PHARMACEUTICALS INCORPORATED — Food and Beverage In-kind items and services $18.04 General
10/09/2024 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $22.73 General
Category: Opioid Analgesic
10/02/2024 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $22.73 General
Category: Opioid Analgesic
09/24/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug), RELISTOR Food and Beverage In-kind items and services $18.59 General
Category: Gastroenterology
09/17/2024 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $22.18 General
Category: Opioid Analgesic
08/19/2024 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $21.22 General
Category: Opioid Analgesic
08/08/2024 Averitas Pharma Inc. QUTENZA (Drug) Food and Beverage In-kind items and services $106.04 General
Category: PAIN MANAGEMENT
07/31/2024 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $23.61 General
Category: Opioid Analgesic
06/26/2024 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $19.80 General
Category: Opioid Analgesic
06/12/2024 Averitas Pharma Inc. QUTENZA (Drug) Food and Beverage In-kind items and services $23.72 General
Category: PAIN MANAGEMENT
05/14/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug), RELISTOR Food and Beverage In-kind items and services $18.23 General
Category: Gastroenterology
05/08/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $16.44 General
Category: NEUROSCIENCE
04/26/2024 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $22.44 General
Category: Opioid Analgesic
04/04/2024 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $23.93 General
Category: Opioid Analgesic
03/15/2024 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $23.53 General
Category: Opioid Analgesic
02/20/2024 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $23.72 General
Category: Opioid Analgesic
12/06/2023 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $21.06 General
Category: Opioid Analgesic
11/15/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug) Food and Beverage In-kind items and services $19.31 General
Category: Gastroenterology
10/04/2023 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $21.94 General
Category: Opioid Analgesic
09/20/2023 Boston Scientific Corporation WaveWriter Alpha Prime 16 (Device) Food and Beverage In-kind items and services $14.48 General
Category: WaveWriter Alpha_NMD
05/17/2023 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $18.64 General
Category: Opioid Analgesic
123…9»

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 23 1,506 2,966 $2.3M $321,547
2022 31 2,033 3,933 $1.6M $333,510
2021 27 1,985 5,626 $2.4M $447,357
2020 31 2,592 8,908 $2.4M $458,562
Total Patients
8,116
Total Services
21,433
Medicare Billing
$1.6M
Procedure Codes
115

All Medicare Procedures & Services

115 procedure records from CMS Medicare Utilization — Page 1 of 5

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms Office 2023 246 465 $345,960 $89,438 25.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 377 770 $321,604 $60,523 18.8%
80307 Testing for presence of drug, by chemistry analyzers Office 2023 367 958 $167,650 $58,088 34.6%
J7999 Compounded drug, not otherwise classified Office 2023 24 61 $976,000 $54,523 5.6%
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms Office 2023 84 107 $61,846 $16,420 26.6%
64635 Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint Facility 2023 31 35 $48,818 $6,650 13.6%
64493 Injection of lower or sacral spine facet joint using imaging guidance, single level Facility 2023 27 50 $49,895 $4,466 9.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 50 64 $18,822 $3,781 20.1%
64633 Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint Facility 2023 17 23 $31,096 $3,295 10.6%
64483 Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level Facility 2023 24 35 $27,510 $3,137 11.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 24 24 $13,008 $2,754 21.2%
64490 Injection of upper or middle spine facet joint using imaging guidance, single level Facility 2023 15 27 $17,550 $2,706 15.4%
64494 Injection of lower or sacral spine facet joint using imaging guidance, second level Facility 2023 27 50 $25,968 $2,572 9.9%
76942 Ultrasonic guidance for needle placement Office 2023 25 61 $11,300 $2,298 20.3%
62369 Electronic analysis reprogramming and refill of spinal canal drug infusion pump Office 2023 18 38 $11,515 $2,229 19.4%
64636 Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint Facility 2023 32 36 $56,450 $2,189 3.9%
64491 Injection of upper or middle spine facet joint using imaging guidance, second level Facility 2023 15 27 $8,938 $1,588 17.8%
62370 Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician Office 2023 17 24 $7,488 $1,489 19.9%
64634 Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint Facility 2023 17 24 $31,200 $1,207 3.9%
64484 Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level Facility 2023 15 21 $7,434 $740.74 10.0%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2023 19 19 $4,370 $648.93 14.8%
62368 Electronic analysis and reprogramming of spinal canal drug infusion pump Office 2023 12 18 $2,592 $562.13 21.7%
80305 Testing for presence of drug, read by direct observation Office 2023 23 29 $4,350 $242.69 5.6%
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms Office 2022 327 645 $479,880 $125,689 26.2%
80307 Testing for presence of drug, by chemistry analyzers Office 2022 458 1,221 $213,675 $74,635 34.9%
123…5»

About Dr. Noemi Salang Ramsay, MD

Dr. Noemi Salang Ramsay, MD is a Anesthesiology healthcare provider based in Little Rock, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508822735.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Noemi Salang Ramsay, MD has received a total of $3,758 in payments from pharmaceutical and medical device companies, with $517.42 received in 2024. These payments were reported across 203 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($3,758).

As a Medicare-enrolled provider, Salang Ramsay has provided services to 8,116 Medicare beneficiaries, totaling 21,433 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 115 distinct procedure/service records.

Practice Information

  • Specialty Anesthesiology
  • Other Specialties Pain Medicine, Pain Medicine
  • Location Little Rock, AR
  • Active Since 04/25/2006
  • Last Updated 04/06/2022
  • Taxonomy Code 207L00000X
  • Entity Type Individual
  • NPI Number 1508822735

Products in Payments

  • XTAMPZA (Drug) $508.90
  • Morphabond ER (Drug) $502.22
  • Belbuca (Drug) $387.59
  • Zilretta (Drug) $216.66
  • Movantik (Drug) $215.82
  • ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $142.84
  • RELISTOR (Drug) $138.69
  • QUTENZA (Drug) $129.76
  • MOVANTIK (Drug) $127.96
  • Lucemyra/Lofexidine (Drug) $127.76
  • LYRICA (Drug) $97.83
  • PRIMARY CARE - DISEASE STATE (Drug) $97.46
  • EMBEDA (Drug) $91.50
  • EMGALITY (Drug) $88.06
  • RESTORE (Device) $78.25
  • SPRIX (Drug) $65.77
  • AIMOVIG (Biological) $60.59
  • Aimovig (Biological) $59.31
  • SPECTRA WAVEWRITER (Device) $57.90
  • BOTOX (Biological) $50.03

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Anesthesiology Doctors in Little Rock

Julio Olaya, M.d, M.D

Anesthesiology — Payments: $22,896

Anesthesiology $22,896

Gregory Smith, M.d, M.D

Anesthesiology — Payments: $15,070

Anesthesiology $15,070

Majid Saleem, Md, MD

Anesthesiology — Payments: $10,579

Anesthesiology $10,579

Dr. Aparna Jindal, Md, MD

Anesthesiology — Payments: $6,860

Anesthesiology $6,860

Ahmed Ghaleb, Md, MD

Anesthesiology — Payments: $6,435

Anesthesiology $6,435

Mr. Mikhail Ivanovsky, Md, MD

Anesthesiology — Payments: $4,564

Anesthesiology $4,564